Suspected Acute Mesenteric Ischemia
Severe abdominal pain out of proportion to exam, especially with vascular/cardiac history
All Pathways
GastroenterologyEmergency
Acute Mesenteric Ischemia Management (ESVS 2017)
Acute Mesenteric Ischemia Management (ESVS 2017): Suspected Acute Mesenteric Ischemia → Clinical Recognition - High Index of Suspicion → Laboratory Stud...
Pathway Overview
14 steps
Algorithm Steps
14 total
01Start 02Action Clinical Recognition - High Index of Suspicion
Classic presentation often absent
- Sudden severe abdominal pain (80%)
- Pain out of proportion to physical exam
- Risk factors: AF, recent MI, CHF, atherosclerosis, hypercoagulable
- GI emptying (vomiting, diarrhea early)
- Peritonitis = late sign (bowel necrosis)
03Action Laboratory Studies
Supportive but not diagnostic
- Lactate (elevated but non-specific)
- D-dimer (elevated in most cases)
- WBC (often elevated)
- Metabolic acidosis (late)
- Normal labs do NOT rule out AMI
04Decision AMI Subtype
Determines treatment approach
- Arterial embolism (~50%): AF, abrupt onset
- Arterial thrombosis (~25%): atherosclerosis, subacute
- MVT (~10%): hypercoagulable, portal HTN
- NOMI (~15%): hypoperfusion, vasoconstrictors
05Action Immediate Resuscitation
Start in parallel with workup
- IV fluids - aggressive resuscitation
- Correct acidosis/electrolytes
- Broad-spectrum antibiotics
- Anticoagulation (UFH) unless contraindicated
- NG decompression
- Avoid vasopressors if possible (worsen ischemia)
06Decision Signs of Bowel Necrosis/Peritonitis?
Peritoneal signs, free air, pneumatosis
07Warning ⚠️ Emergent Laparotomy
Necrotic bowel requires surgical resection
- Resect non-viable bowel
- Revascularization (embolectomy, bypass)
- Second-look laparotomy at 24-48h
- Damage control if unstable
- Mortality 50-80%
08Action Post-Treatment Care
ICU monitoring, nutrition, complications
- ICU monitoring
- Second-look surgery if needed
- Short bowel syndrome risk if extensive resection
- Long-term anticoagulation
- Address underlying cause (AF, hypercoagulable workup)
09Outcome Survival
Early diagnosis critical - overall mortality 50-80%
10Outcome Short Bowel Syndrome
If extensive resection required - may need long-term TPN
11Action Endovascular/Hybrid Approach
If no peritonitis and viable bowel
- Catheter-directed thrombolysis
- Mechanical thrombectomy
- Angioplasty + stenting
- May combine with laparoscopy to assess bowel
- Consider surgical backup
- Path rejoins step 08Shared downstream outcome
12Action MVT-Specific Treatment
Anticoagulation is primary therapy
- Systemic anticoagulation (UFH → LMWH/warfarin/DOAC)
- Duration: 6+ months (often lifelong)
- Catheter-directed thrombolysis if progressing
- Surgery only if bowel necrosis
- Path rejoins step 08Shared downstream outcome
13Action NOMI Treatment
Non-occlusive mesenteric ischemia
- Treat underlying cause (shock, CHF)
- Discontinue vasoconstrictors if possible
- Intra-arterial papaverine/vasodilators
- Optimize cardiac output
- Surgery if bowel necrosis develops
- Path rejoins step 08Shared downstream outcome
14Action CT Angiography (CTA)
Gold standard - obtain URGENTLY
- Arterial + portal venous phase
- Sensitivity/specificity >95%
- Shows: SMA occlusion, bowel wall changes, pneumatosis
- MVT: venous thrombus, bowel edema
- Do NOT delay for other studies
- Path rejoins step 04Shared downstream outcome
Guideline Source
ESVS 2017 Clinical Practice Guidelines on the Management of Acute Mesenteric Ischaemia
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- High mortality rate even with treatment (50-80%)
- Time-sensitive - requires rapid diagnosis
- CT angiography is gold standard but interpretation requires expertise
- Treatment approach depends on local surgical/IR expertise
- NOMI treatment differs from occlusive disease
Applicable Regions
USEUGlobal
EU: ESVS 2017 is current standard
US: Similar management principles as European guidelines
Version 1Next review: 2027-01-01
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Calculator
Glasgow-Blatchford Bleeding Score
Upper GI bleed risk stratification and need for intervention
Open page
Compare
AttendMe.ai vs UpToDate
See how this pathway workflow compares against UpToDate.
Open page
Commercial
Start free
Run the pathway in a live AttendMe account with citations and tracked usage.
Start free
Related Resources
Frequently Asked Questions
What is the Acute Mesenteric Ischemia Management (ESVS 2017)?
The Acute Mesenteric Ischemia Management (ESVS 2017) is a emergency clinical algorithm for Gastroenterology. It provides a structured decision tree to guide clinical decision-making, based on ESVS 2017 Clinical Practice Guidelines on the Management of Acute Mesenteric Ischaemia.
What guideline is the Acute Mesenteric Ischemia Management (ESVS 2017) based on?
This algorithm is based on ESVS 2017 Clinical Practice Guidelines on the Management of Acute Mesenteric Ischaemia (DOI: 10.1016/j.ejvs.2017.01.010).
What are the limitations of the Acute Mesenteric Ischemia Management (ESVS 2017)?
Known limitations include: High mortality rate even with treatment (50-80%); Time-sensitive - requires rapid diagnosis; CT angiography is gold standard but interpretation requires expertise; Treatment approach depends on local surgical/IR expertise; NOMI treatment differs from occlusive disease. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Acute Mesenteric Ischemia Management (ESVS 2017) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free